SEC Tracker
Get the app

Stoke Therapeutics STOK

A Levin Arthur (Director) plans to sell 605 STOK shares, about $22,070

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Mar 13, 2026
  2. Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  3. Shares acquired by: Restricted Stock Units
  4. 10b5-1 plan adopted: Nov 12, 2025

All of A Levin Arthur's insider filings, holdings and planned sales

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Stoke Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Trevi Therapeutics TRVI public float $588M, Jun 30, 2025
  2. Mersana Therapeutics MRSN
  3. Evolus EOLS public float $560M, Jun 30, 2025
  4. Xencor XNCR public float $556M, Jun 30, 2025
  5. Amphastar Pharmaceuticals AMPH public float $633M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.